Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02494024
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy
C2N Diagnostics 32
Not applicableWithdrawnNCT06711510
What this trial is testing

Predict to Prevent PGRN Disease

Who this might be right for
Frontotemporal Dementia (FTD)GRN Related Frontotemporal Dementia
Assistance Publique - Hôpitaux de Paris
Early research (Phase 1)Study completedNCT00058227
What this trial is testing

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular Lymphoma+40 more
National Cancer Institute (NCI) 37
Not applicableStudy completedNCT01471873
What this trial is testing

Variability of Pentacam-derived Back Elevation Measurements in Keratoconus and Cross-linked Corneas

Who this might be right for
Keratoconus
Democritus University of Thrace 67
Testing effectiveness (Phase 2)Study completedNCT00005903
What this trial is testing

Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy
National Institute of Neurological Disorders and Stroke (NINDS) 15
Testing effectiveness (Phase 2)UnknownNCT05917561
What this trial is testing

Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo

Who this might be right for
Vitiligo
University Hospital, Bordeaux 48
Early research (Phase 1)Not Yet RecruitingNCT07732413
What this trial is testing

Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive Pediatric Brain Cancer

Who this might be right for
Progressive Pediatric Brain Cancer
Lumos Pharma 30
Testing effectiveness (Phase 2)Study completedNCT01982942
What this trial is testing

Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
MediciNova 255
Early research (Phase 1)Study completedNCT04539041
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy (PSP)
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Ended earlyNCT01212094
What this trial is testing

Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 44
Not applicableStudy completedNCT02821780
What this trial is testing

CADASIL Disease Discovery

Who this might be right for
Germline Mutation in the NOTCH 3 GeneCardiovascular DiseaseArterial Stiffness+2 more
National Heart, Lung, and Blood Institute (NHLBI) 20
Not applicableStudy completedNCT02025413
What this trial is testing

Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method

Who this might be right for
Metastatic Progressive Castration-resistant Prostate CancerMetastatic Progressive Breast Cancer
Duke University 46
Not applicableStudy completedNCT05437159
What this trial is testing

Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech

Who this might be right for
Stuttering, DevelopmentalAphasia, Primary Progressive
Boston University Charles River Campus 278
Large-scale testing (Phase 3)Ended earlyNCT05130866
What this trial is testing

Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas

Who this might be right for
Neurofibromatosis Type 2
Recursion Pharmaceuticals Inc. 25
Testing effectiveness (Phase 2)Looking for participantsNCT07003542
What this trial is testing

And Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Who this might be right for
GlioblastomaBrain Tumor
Case Comprehensive Cancer Center 48
Not applicableStudy completedNCT02675270
What this trial is testing

Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia

Who this might be right for
Aphasia, Primary ProgressiveAnomiaAlzheimer Disease
Georgetown University 84
Not applicableStudy completedNCT05695482
What this trial is testing

Progressive Resistance Training Compared to Neuromuscular Exercises on Knee Kinematics

Who this might be right for
Dynamic Knee ValgusInjury Prevention
University of Thessaly 53
Not applicableNot Yet RecruitingNCT07631923
What this trial is testing

Acute Intermittent Hypoxia Combined With Gait Training in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+1 more
Shirley Ryan AbilityLab 35
Not applicableStudy completedNCT02764554
What this trial is testing

Post-Marketing Surveillance of Lenvima in Korean Patients

Who this might be right for
Differentiated Thyroid Carcinoma (DTC)
Eisai Korea Inc. 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05703997
What this trial is testing

FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction

Who this might be right for
Small Cell Lung Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 20
Next Page